GlobeNewswire Inc | Dec 7, 2020 04:30PM EST

December 07, 2020

BASKING RIDGE, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management is scheduled to present at the 13th Annual LD Micro Main Event Conference.

Presentation details:

Date: Monday, December 14, 2020

Time: 2:40-3:00pm EDT

Investors can register for the conference HERE.

Following the conference a webcast replay of the presentation will be available on the Investor section of the companys website, www.electrocore.com.

About electroCore, Inc.

electroCore, Inc. is a commercial-stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:

Hans VitzthumLifeSci Advisors617-430-7578hans@lifesciadvisors.com

or

Media Contact:

Jackie DorskyelectroCore 973-290-0097jackie.dorsky@electrocore.com